Aldeyra Therapeutics & Philip Kim
1 shared events · Importance 3 · Last updated May 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Regulatory
Aldeyra Therapeutics: Aldeyra Therapeutics is the defendant in a securities class action lawsuit, accused of making false and misleading statements regarding its reproxalap clinical trials, which could lead to significant financial damages.
Philip Kim: Philip Kim is an attorney at Rosen Law Firm and a contact person for investors interested in joining the Aldeyra Therapeutics class action lawsuit.
May 03, 2026 · 8 articles
NEWSDESK
Explore this relationship live
Track how Aldeyra Therapeutics and Philip Kim interact across events, view sentiment trends, and discover connected entities.
Open Dashboard